| dbo:abstract |
Gemopatrilat (INN) is an experimental drug that was never marketed. It acts as a vasopeptidase inhibitor. It inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase (neprilysin). (en) |
| dbo:casNumber |
160135-92-2 |
| dbo:chEMBL |
107747 |
| dbo:fdaUniiCode |
MU9089C77W |
| dbo:kegg |
D04312 |
| dbo:pubchem |
9886079 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Gemopatrilat.svg?width=300 |
| dbo:wikiPageID |
27364746 (xsd:integer) |
| dbo:wikiPageLength |
3759 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1032232433 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Enzyme_inhibitor dbr:Neprilysin dbr:International_nonproprietary_name dbc:Abandoned_drugs dbc:Acetic_acids dbc:Lactams dbc:Thiols dbr:Drug dbc:Azepanes dbc:Carboxamides dbr:Angiotensin-converting_enzyme dbc:ACE_inhibitors |
| dbp:atcPrefix |
None (en) |
| dbp:c |
19 (xsd:integer) |
| dbp:casNumber |
160135 (xsd:integer) |
| dbp:chembl |
107747 (xsd:integer) |
| dbp:chemspiderid |
8061752 (xsd:integer) |
| dbp:h |
26 (xsd:integer) |
| dbp:iupacName |
-Hexahydro-6-[-α-mercaptohydrocinnamido]-2,2-dimethyl-7-oxo-1H-azepine-1-acetic acid (en) |
| dbp:kegg |
D04312 (en) |
| dbp:n |
2 (xsd:integer) |
| dbp:o |
4 (xsd:integer) |
| dbp:pubchem |
9886079 (xsd:integer) |
| dbp:s |
1 (xsd:integer) |
| dbp:smiles |
CC1C (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
YRSVDSQRGBYVIY-GJZGRUSLSA-N (en) |
| dbp:synonyms |
BMS-189921 (en) |
| dbp:unii |
MU9089C77W (en) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Reflist dbt:Cardiovascular-drug-stub dbt:Agents_acting_on_the_renin-angiotensin_system dbt:Angiotensin_receptor_modulators |
| dcterms:subject |
dbc:Abandoned_drugs dbc:Acetic_acids dbc:Lactams dbc:Thiols dbc:Azepanes dbc:Carboxamides dbc:ACE_inhibitors |
| gold:hypernym |
dbr:Drug |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAmides yago:Abstraction100002137 yago:AceticAcid114599168 yago:Acid114607521 yago:Amide114724264 yago:CarboxylicAcid114739360 yago:Chemical114806838 yago:Compound114818238 yago:Material114580897 yago:Matter100020827 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:WikicatAceticAcids |
| rdfs:comment |
Gemopatrilat (INN) is an experimental drug that was never marketed. It acts as a vasopeptidase inhibitor. It inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase (neprilysin). (en) |
| rdfs:label |
Gemopatrilat (en) |
| owl:sameAs |
freebase:Gemopatrilat yago-res:Gemopatrilat wikidata:Gemopatrilat dbpedia-sh:Gemopatrilat dbpedia-sr:Gemopatrilat https://global.dbpedia.org/id/4khaY |
| prov:wasDerivedFrom |
wikipedia-en:Gemopatrilat?oldid=1032232433&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Gemopatrilat.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Gemopatrilat |
| is dbo:wikiPageWikiLink of |
dbr:Endopeptidase_inhibitor dbr:C19H26N2O4S dbr:Omapatrilat |
| is foaf:primaryTopic of |
wikipedia-en:Gemopatrilat |
